Integra LifeSciences Cor...

AI Score

XX

Unlock

16.21
-0.78 (-4.59%)
At close: Apr 14, 2025, 1:15 PM
-4.59%
Bid 16.13
Market Cap 1.25B
Revenue (ttm) 1.61B
Net Income (ttm) -6.94M
EPS (ttm) -0.09
PE Ratio (ttm) -180.11
Forward PE 10.35
Analyst Hold
Ask 16.26
Volume 206,976
Avg. Volume (20D) 684,762
Open 17.06
Previous Close 16.99
Day's Range 16.19 - 17.42
52-Week Range 15.95 - 33.04
Beta 1.25

About IART

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracrani...

Sector Healthcare
IPO Date Aug 16, 1995
Employees 4,396
Stock Exchange NASDAQ
Ticker Symbol IART
Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for IART stock is "Hold." The 12-month stock price forecast is $25, which is an increase of 54.23% from the latest price.

Stock Forecasts

Next Earnings Release

Integra LifeSciences Corporation is scheduled to release its earnings on May 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+12.11%
Integra LifeSciences shares are trading higher aft... Unlock content with Pro Subscription
5 months ago
+25.1%
Integra LifeSciences shares are trading higher after the company reported better-than-expected Q3 financial results.